Expertise in
13
conditions

Peter N. Young

Medical Park, Reithof Park, 
Bad Feilnbach, BY, DE 
Expertise in
13
conditions
Medical Park, Reithof Park, 
Bad Feilnbach, BY, DE 

Overview

Peter Young practices practicing medicine in Bad Feilnbach, Germany.

Mr. Young is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Pompe Disease, Charcot-Marie-Tooth Disease, Idiopathic Hypersomnia, and Periodic Limb Movement Disorder.

He is actively involved in clinical research, co-authoring 140 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Medical Park, Reithof Park, Bad Feilnbach, BY, Germany
Other Locations
Muenster, NW, Germany
Munich, BY, Germany
Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Multicenter, Prospective, Randomized, Placebo-controlled, Double-blind, Parallel-group Clinical Trial to Assess the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Participants With Post-Polio Syndrome
A Multicenter, Prospective, Randomized, Placebo-controlled, Double-blind, Parallel-group Clinical Trial to Assess the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Participants With Post-Polio Syndrome
Enrollment Status: Terminated
Publish Date: December 05, 2025
Intervention Type: Biological, Drug
Study Drug: Flebogamma
Study Phase: Phase 2/Phase 3
International, Multi-center, Open Label, Follow-up Extension Study Assessing the Long-term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
International, Multi-center, Open Label, Follow-up Extension Study Assessing the Long-term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
Enrollment Status: Unknown
Publish Date: February 20, 2024
Intervention Type: Drug
Study Drug: PXT3003
Study Phase: Phase 3
A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
Enrollment Status: Completed
Publish Date: November 12, 2020
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
Enrollment Status: Terminated
Publish Date: June 14, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

138 Total Publications

Tablet-Assisted Speech and Language Therapy for Acute Post-Stroke Aphasia: A Randomized Clinical Trial (LEXI Study).
Tablet-Assisted Speech and Language Therapy for Acute Post-Stroke Aphasia: A Randomized Clinical Trial (LEXI Study).
Journal: European journal of neurology
Published: September 05, 2025

Frequently Asked Questions about Peter N. Young

Is Peter N. Young a top-rated expert for Pompe Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Peter N. Young is classified as an Advanced expert for Pompe Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Peter N. Young participate in research or clinical trials?

Yes. Peter N. Young has published 138 articles and abstracts on conditions like Pompe Disease. You can view a list of Peter N. Young's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Young's expertise for a condition
ConditionClose
      View All 13 Advanced Conditions
      View All 30 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile